NASDAQ:MDXH MDxHealth - MDXH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. $3.24 +0.09 (+2.86%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.13▼$3.3750-Day Range$2.61▼$7.1552-Week Range$2.47▼$10.95Volume126,021 shsAverage Volume220,733 shsMarket Capitalization$52.78 millionP/E RatioN/ADividend YieldN/APrice Target$12.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media MDxHealth MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside270.4% Upside$12.00 Price TargetShort InterestHealthy0.22% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.09Based on 10 Articles This WeekInsider TradingAcquiring Shares$4 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.22) to ($1.02) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.16 out of 5 starsMedical Sector323rd out of 996 stocksMedical Laboratories Industry9th out of 25 stocks 3.5 Analyst's Opinion Consensus RatingMDxHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.00, MDxHealth has a forecasted upside of 270.4% from its current price of $3.24.Amount of Analyst CoverageMDxHealth has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.22% of the float of MDxHealth has been sold short.Short Interest Ratio / Days to CoverMDxHealth has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MDxHealth has recently decreased by 14.18%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMDxHealth does not currently pay a dividend.Dividend GrowthMDxHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MDXH. Previous Next 1.1 News and Social Media Coverage News SentimentMDxHealth has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.33 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for MDxHealth this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for MDXH on MarketBeat in the last 30 days. This is a decrease of -70% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added MDxHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, MDxHealth insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,000,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.70% of the stock of MDxHealth is held by insiders.Percentage Held by InstitutionsOnly 12.56% of the stock of MDxHealth is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for MDxHealth are expected to grow in the coming year, from ($1.22) to ($1.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MDxHealth is -1.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MDxHealth is -1.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMDxHealth has a P/B Ratio of 5.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About MDxHealth (NASDAQ:MDXH) StockMDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.Read More Receive MDXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address MDXH Stock News HeadlinesApril 2, 2023 | americanbankingnews.comMDxHealth (MDXH) vs. Its Rivals Head to Head SurveyApril 2, 2023 | americanbankingnews.comContrasting MDxHealth (MDXH) and Its CompetitorsApril 2, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.April 2, 2023 | americanbankingnews.comMDxHealth (MDXH) and Its Peers Critical ContrastMarch 31, 2023 | americanbankingnews.comHead-To-Head Survey: MDxHealth (MDXH) & Its CompetitorsMarch 31, 2023 | americanbankingnews.comMDxHealth (MDXH) versus Its Rivals Financial AnalysisMarch 30, 2023 | americanbankingnews.comMDxHealth (MDXH) and Its Rivals Head to Head ReviewMarch 30, 2023 | americanbankingnews.comMDxHealth (MDXH) & Its Peers Critical ContrastApril 2, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.March 30, 2023 | americanbankingnews.comReviewing MDxHealth (MDXH) and Its PeersMarch 28, 2023 | americanbankingnews.comReviewing MDxHealth (MDXH) and The CompetitionMarch 27, 2023 | americanbankingnews.comMDxHealth (MDXH) & Its Competitors Head-To-Head ReviewMarch 26, 2023 | americanbankingnews.comMDxHealth (MDXH) and Its Competitors Financial AnalysisMarch 24, 2023 | americanbankingnews.comMDxHealth (NASDAQ:MDXH) Coverage Initiated by Analysts at William BlairMarch 15, 2023 | marketwatch.comMetabolomic Platform Market Size, Growth | Soaring Demand | 2023 - 2029March 15, 2023 | marketwatch.comProstate Cancer Screening Market 2023-2030 With Highly Productive Segment To Expand OutstandinglyMarch 13, 2023 | finance.yahoo.comMDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate BankMarch 9, 2023 | finanznachrichten.demdxhealth: MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023March 8, 2023 | finance.yahoo.comMDxHealth Announces Update of Outstanding Shares and Voting RightsMarch 6, 2023 | finance.yahoo.comMDxHealth Announces Exercise of OptionMarch 3, 2023 | marketwatch.comOncology Precision Medicine Market Environment Development Trend in 2023March 1, 2023 | msn.com$4M Bet On MDxHealth? Check Out These 4 Penny Stocks Insiders Are BuyingMarch 1, 2023 | finance.yahoo.comMDxHealth to Participate in 43rd Annual Cowen Healthcare ConferenceFebruary 22, 2023 | finance.yahoo.comMDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023February 15, 2023 | finance.yahoo.comMDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial CalendarFebruary 15, 2023 | finance.yahoo.comMDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial CalendarFebruary 13, 2023 | finance.yahoo.comMDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) TestSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MDXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address MDXH Company Calendar Today4/02/2023Next Earnings (Estimated)4/26/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MDXH CUSIPN/A CIK1872529 Webmdxhealth.com Phone324-364-2070FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Forecast$12.00 High Stock Price Forecast$18.00 Low Stock Price Forecast$8.00 Forecasted Upside/Downside+270.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.90) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-44,040,000.00 Net Margins-118.86% Pretax Margin-118.86% Return on Equity-218.20% Return on Assets-44.01% Debt Debt-to-Equity Ratio4.08 Current Ratio1.59 Quick Ratio1.47 Sales & Book Value Annual Sales$37.05 million Price / Sales1.42 Cash FlowN/A Price / Cash FlowN/A Book Value$0.57 per share Price / Book5.68Miscellaneous Outstanding Shares16,290,000Free Float16,011,000Market Cap$52.78 million OptionableNot Optionable Beta0.29 Key ExecutivesMr. Michael K. McGarrity (Age 59)CEO & Exec. Director Comp: $502.44kMr. Ron Kalfus (Age 48)Chief Financial Officer Mr. Joseph Sollee (Age 57)Exec. VP of Corp. Devel. & Gen. Counsel Mr. John A. Bellano (Age 53)Chief Commercial Officer Ms. Miriam Reyes (Age 49)Exec. VP of Operations Dr. Wim Van Criekinge (Age 50)Chief Scientific Officer Mr. Paul MarrExec. VP of Sales for North AmericaMore ExecutivesKey CompetitorsExagenNASDAQ:XGNAkuminNASDAQ:AKUPsychemedicsNASDAQ:PMDCentogeneNASDAQ:CNTGGenetronNASDAQ:GTHView All CompetitorsInsiders & InstitutionsMVM Partners LLCBought 916,666 shares on 2/13/2023Ownership: 5.627%Mvm Partners, LlcBought 1,000,000 shares on 2/3/2023Total: $4 M ($4.00/share)View All Insider TransactionsView All Institutional Transactions MDXH Stock - Frequently Asked Questions Should I buy or sell MDxHealth stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MDXH shares. View MDXH analyst ratings or view top-rated stocks. What is MDxHealth's stock price forecast for 2023? 4 Wall Street analysts have issued 1-year target prices for MDxHealth's stock. Their MDXH share price forecasts range from $8.00 to $18.00. On average, they predict the company's stock price to reach $12.00 in the next year. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for MDXH or view top-rated stocks among Wall Street analysts. How have MDXH shares performed in 2023? MDxHealth's stock was trading at $6.61 on January 1st, 2023. Since then, MDXH stock has decreased by 51.0% and is now trading at $3.24. View the best growth stocks for 2023 here. When is MDxHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023. View our MDXH earnings forecast. When did MDxHealth IPO? (MDXH) raised $45 million in an IPO on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share. What is MDxHealth's stock symbol? MDxHealth trades on the NASDAQ under the ticker symbol "MDXH." How do I buy shares of MDxHealth? Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is MDxHealth's stock price today? One share of MDXH stock can currently be purchased for approximately $3.24. How much money does MDxHealth make? MDxHealth (NASDAQ:MDXH) has a market capitalization of $52.78 million and generates $37.05 million in revenue each year. The company earns $-44,040,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis. How can I contact MDxHealth? MDxHealth's mailing address is CAP Business Center, Herstal, Liege 4040. The official website for the company is mdxhealth.com. The company can be reached via phone at 324-364-2070 or via email at ir@mdxhealth.com. This page (NASDAQ:MDXH) was last updated on 4/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.